HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Braslis, K. G. Articles by Hardy, K. J. Search for Related Content PubMed PubMed Citation Articles by Braslis, K. G. Articles by Hardy, K. J.

Calcitonin gene-related peptide (CGRP) is a product of the calcitonin gene with a widespread distribution in neural tissue of the brain, gut and perivascular nerves. Infusion of CGRP produces multiple biological effects, but the physiological significance of these findings will be influenced by the sites and rates of CGRP metabolism.

The metabolic clearance rate and half-life of disappearance of human CGRP were estimated in conscious sheep after infusing CGRP at 1 or 5 pmol/kg per min to steady-state conditions. The particular organs involved in the clearance of CGRP were assessed by measuring the inflow and outflow concentrations across the liver, gut, kidney, lung and brain.

The metabolic clearance rate at steady state was 22·6 ± 2·1 (S.E.M.) and 15·0±1·7 ml/kg per min for the 1 and 5 pmol/kg per min doses respectively. The half-life of disappearance was bi-exponential: 3·6±0·3 min for the first phase and 13·6±1·0 min for the second phase. High-pressure liquid chromatography of plasma at equilibrium revealed only a single peak coeluting with CGRP(1–37): no immunoreactive metabolites were detected. These pharmacokinetic values are intermediate between that of a neurotransmitter and a hormone and are therefore consistent for a peptide with both circulatory and neurotransmitter modes of action. The kidney, with an arterial–renal vein gradient of 14%, and the liver, with a portal– hepatic vein gradient of 25%, were the major organs involved in the clearance of CGRP. The specific organ clearance, however, accounted for only one-third of the whole body metabolic clearance rate of CGRP, suggesting that other more generalized degradative systems are involved, such as endothelial-bound enzymes of blood vessels. This information on clearance and organ-specific metabolism should form a basis for evaluating the physiological roles and modes of action of CGRP.

J. Endocr. (1988) 118,25–31

This article has been cited by other articles:

				F. Birklein, M. Schmelz, S. Schifter, and M. Weber The important role of neuropeptides in complex regional pain syndrome Neurology, December 26, 2001; 57(12): 2179 - 2184. [Abstract] [Full Text] [PDF]

				M. Zhou, A. J. Arthur, Z. F. Ba, I. H. Chaudry, and P. Wang The small intestine plays an important role in upregulating CGRP during sepsis Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2001; 280(2): R382 - R388. [Abstract] [Full Text] [PDF]

				B. Z. Atkins, S. C. Silvestry, R. N. Samy, A. S. Shah, D. C. Sabiston Jr, and D. D. Glower CALCITONIN GENE-RELATED PEPTIDE ENHANCES THE RECOVERY OF CONTRACTILE FUNCTION IN STUNNED MYOCARDIUM J. Thorac. Cardiovasc. Surg., June 1, 2000; 119(6): 1246 - 1254. [Abstract] [Full Text] [PDF]